3rd Quarter - Report

LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Pharmaceutical Supply Chain. H.R.2213: Medical Supply Chain Resiliency Act. Issues related to the 340(b) program. H.R.1492/S.832: EPIC Act of 2025.

LobbyistCovered position, as disclosed
SOPHIE KHANAHMADI Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions
ALANNA TEMME Legislative Director, U.S. Representative Jon Porter

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 832 (119th), H.R. 2213 (119th), H.R. 1492 (119th)

Trade (domestic/foreign) TRD

Issues related to USTR/trade.

LobbyistCovered position, as disclosed
SOPHIE KHANAHMADI —
ALANNA TEMME —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.